Andre Broussard, D.C.
NSAIDs and COX-2 inhibitors impede tendon, bone and cartilage repair
NSAIDs are not appropriate for neurogenic pain with no
prostaglandin-mediated inflammation.
/By //Matt Hasson/
ORTHOPAEDICS TODAY INTERNATIONAL 2006; 9:12
*September 2006*
INNSBRUCK, Austria -- Recent biochemical research suggests that NSAIDs
are appropriate for prostaglandin- mediated inflammation, not
"neurogenic inflammation" associated with tendinopathy.
The upshot: COX-2 inhibitors impair tendon and bone healing, two leading
experts said.
Physicians have typically treated patients with tendinopathy but no
inflammation with NSAIDs. However, there are certain chemical and
genetic factors that discourage NSAID use in some patients, said Hakan
Alfredson, MD, of the University of Umea, Sweden.
"In earlier days, the only information we had to rely on was the
information from biopsies," Alfredson said at the 12th ESSKA Congress,
here. "And those biopsies showed us irregular fiber structure, high
concentrations of matrix, vascular ingrowth but no inflammatory cell
traits. But, despite that, we gave these patients tons of NSAIDs. ... We
wanted to use a new method to try to evaluate whether there was any
inflammation in these tendons."
In vivo microdialysis
"If you use NSAIDs together with proteins, certain NSAIDs virtually
block the protein synthesis in the muscle."
-- Hakan Alfredson, MD
Using in vivo microdialysis to study the biochemical properties of
affected tendons, Alfredson and his colleagues tested 20 patients with
tendinopathy and painful knee function. The control group included 12
patients with normal tendons and no pain. Another arm of the study
focused on six patients with jumper's knee. The control group had six
patients with normal tendons, Alfredson said.
The specialists also assessed patients for prostaglandin E2, which is
"essential for a so-called chemical inflammation," Alfredson said. They
found that prostaglandin E2 levels did not differ between the chronic
painful tendons and the normal, pain-free tendons.
"So, the conclusion from those studies was that there is no
prostaglandin-mediated inflammation inside those tendons," he said.
Studying 1,178 knees, Alfredson's group found that several
pro-inflammatory cell proteins were not regulated in the tissue, again
suggesting no prostaglandin-mediated inflammation in the tendons,
Alfredson said.
"It cannot be justified to treat your patients with NSAIDs with this
background," Alfredson said. "It's also important to remember that
certain NSAIDs have negative effects on muscle protein metabolism. So,
if you use NSAIDs together with proteins, certain NSAIDs virtually block
the protein synthesis in the muscle, so that's another negative factor."
NSAIDs also inhibit tenocytes and, during exercise, decrease blood flow,
Alfredson said. Other factors include heavy vascularity and "neurogenic
inflammation," as opposed to prostaglandin-mediated inflammation.
The benefits of prostaglandins
Norwegian specialist Sigbjørn Dimmen, MD, also noted the value of
prostaglandins, which are "responsible for ensuring balance between bone
resorption and bone formation." Decreased prostaglandin may impair bone
healing, and the COX-2 enzyme is critical for fracture healing, he said.
Dimmen and his group tested how short-term doses of parecoxib, a COX-2
inhibitor, and indomethacin, a COX-1 inhibitor, affect long-bone
fracture healing. The parecoxib and indomethacin groups had lower bone
mineral density than the control group.
Also, mechanical testing showed the parecoxib group and control group
demonstrated significant differences in all properties, Dimmen said.
However, parecoxib proved more detrimental.
"So, our findings with parecoxib had the higher delay in the fracture
healing than indomethacin, with the assumption that the COX-2 enzyme is
responsible for impaired fracture healing," he said.
"Never give NSAIDs for stress fractures or for cartilage damage. NSAIDs
hate chondrocytes."
-- Sigbjørn Dimmen, MD
No prospective, randomized clinical trials or evidence-based
measurements have addressed the effects of NSAIDs and COX-2 inhibitors
on long-bone fractures, Dimmen said. Some data show NSAIDs and COX-2
inhibitors cause no nonunions in acetabular fractures, which "might
indicate that you can't see any negative effects from NSAIDs or COX-2
inhibitors in fractures which normally heal well," Dimmen said.
However, he advised colleagues to avoid NSAIDs or COX-2 inhibitors when
treating stress fractures or even when repairing cartilage.
"We know that prostaglandins are necessary for fracture healing," Dimmen
said. "We know that COX-2 is critically involved in fracture healing in
the first 3 weeks after a fracture. And NSAIDs and COX-2 inhibitors both
impair fracture healing.
"I think one should probably avoid NSAIDs and COX-2 inhibitors in all
shock fractures and also other fractures requiring unimpaired fracture
healing," he added. "Never give NSAIDs for stress fractures or for
cartilage damage. NSAIDs hate chondrocytes."
*For more information: *
* Alfredson H, Dimmen S. Non-steriodal anti-inflammatory drugs
and tissue healing. Mini symposium. Presented at the 12th
ESSKA Congress and 5th World Congress on Sports Trauma. May
24-27, 2006. Innsbruck, Austria.
Article suggested by Dr. Jen MC, DC
Comments